erythromycin has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubel, D; Bailey, JE; Daoud-el Baba, M; Fussenegger, M; Fux, C; Heinzen, C; Keller, B; Kramer, BP; Weber, CC; Weber, W | 1 |
| Inoue, K; Matsuo, H; Sakamoto, Y; Sakata, K; Shibazaki, M; Tanaka, K | 1 |
2 other study(ies) available for erythromycin and Fibrosarcoma
| Article | Year |
|---|---|
Macrolide-based transgene control in mammalian cells and mice.
Topics: Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Base Sequence; Cell Line; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Endothelium, Vascular; Erythromycin; Escherichia coli; Female; Fibroblasts; Fibrosarcoma; Gene Expression Regulation; Humans; Kidney; Mice; Molecular Sequence Data; Trans-Activators; Transduction, Genetic; Transgenes; Umbilical Veins | 2002 |
[Effects of macrolide antibiotics to inhibit infiltration and proliferation of malignant tumor cells--in vitro evaluation].
Topics: Anti-Bacterial Agents; Azithromycin; Cell Division; Cell Line; Clarithromycin; Erythromycin; Fibrosarcoma; Humans; Immunologic Factors; Neoplasm Invasiveness; Roxithromycin; Teratocarcinoma; Tumor Cells, Cultured | 1997 |